SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-320937
Filing Date
2021-11-05
Accepted
2021-11-05 07:31:03
Documents
14
Period of Report
2021-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d248800d8k.htm   iXBRL 8-K 25275
2 EX-99.1 d248800dex991.htm EX-99.1 54497
6 GRAPHIC g248800g1105004412804.jpg GRAPHIC 2701
  Complete submission text file 0001193125-21-320937.txt   221943

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20211105.xsd EX-101.SCH 2888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20211105_lab.xml EX-101.LAB 19656
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20211105_pre.xml EX-101.PRE 12312
7 EXTRACTED XBRL INSTANCE DOCUMENT d248800d8k_htm.xml XML 3591
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 211382339
SIC: 2836 Biological Products, (No Diagnostic Substances)